Cash Flow Kringle Pharma, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Sep'24
Sep'23
Sep'22
Sep'21
Sep'20
Sep'19
No of Months
12
12
12
12
12
12
Profit Before Tax
-754.00
-852.00
-330.00
-299.00
-116.00
-301.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
0.00
50.00
77.00
-287.00
-71.00
-12.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-661.00
-689.00
15.00
-560.00
-146.00
-338.00
Cash Flow from Investing Activities
-121.00
-120.00
-254.00
0.00
0.00
0.00
Cash Flow from Financing Activities
838.00
69.00
603.00
595.00
2,082.00
0.00
Net Cash Inflow / Outflow
55.00
-740.00
364.00
34.00
1,936.00
-338.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in JPY Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Kringle Pharma, Inc.
Figures in Million
consolidated Cash Flow Results
Change(JPY)
Change(%)
Profit Before Tax
-754.961
261.903
-1,015.00
-388.26%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
0.005
-75.835
75.00
100.01%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-661.166
236.795
-897.00
-379.21%
Cash Flow from Investing Activities
-121.363
-32.441
-89.00
-274.10%
Cash Flow from Financing Activities
838.233
-73.153
911.00
1245.86%
Net Cash Inflow / Outflow
55.703
131.717
-76.00
-57.71%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0.516
0.00
-100.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Sep'24
YoY Growth in year ended Sep 2024 is 4.05% vs -4,462.47% in Sep 2023
Sep'24
Sep'23
Change(%)
Cash Flow from Operating Activities
-661.17
-689.10
4.05%
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
